-
Department of Defense Collaborates with The Michael J. Fox Foundation for Parkinson's Research to Fund Promising Grant Applications
May 9, 2003
… Michael J. Fox Foundation for Parkinson's Research (MJFF) to fund seven proposals in Parkinson's research submitted … III, United States Army Medical Research and Materiel Command. "MJFF's Fast Track program generated a large draw … grant applications we receive exceeds our allocated budget on a particular program," explained Deborah W. Brooks, …
-
The Michael J. Fox Foundation is Heading to Barcelona, Spain for World Parkinson Congress
June 27, 2023
… The Michael J. Fox Foundation (MJFF) is headed to Barcelona, Spain for the sixth World Parkinson Congress (WPC) event. WPC brings together people and families living with Parkinson’s, … in movement disorders and senior vice president of medical communications at The Michael J. Fox Foundation. Clinical …
-
Parsing the Diverse Neuromodulation of Vulnerable Versus Resistant Dopamine Axons According to Distinct Molecular Subtype
… release dopamine are lost in Parkinson’s disease leading to debilitating problems. Recent research has revealed … the distinct dopamine neuron subtypes. If we could identify how these mechanisms differ between vulnerable versus … in Parkinson’s. This may inform the development of targeted and improved strategies to rescue DA dysfunction and …
-
Actor Alan Alda Reveals His Parkinson's Diagnosis: 'It's like a puzzle to be solved'
July 31, 2018
… Today, during an appearance on "CBS This Morning," Emmy- and … I've acted, I've given talks, I help at the Alda Center for Communicating Science at Stony Brook. I started this new … his initial reaction to a Parkinson's diagnosis and how he views his disease: "I was mainly helping my family …
-
Michael J. Fox Foundation Commits up to $12 Million for Targeted Parkinson's Therapeutic Development in 2010
September 15, 2009
… NEWYORK, NY — The Michael J. Fox Foundation has committed up to $12 million in 2010 funding for prioritized research … our understanding or treatment of PD. Validating Novel Targets: Support for work demonstrating whether modulation of a …
-
Exploring a Novel Neurotrophic Factor to Protect the Nigrostriatal Dopaminergic System and Alleviate Motor Deficits
… major challenges in developing novel neuroprotective agents to treat Parkinson’s disease (PD) patients. This project … PD. The hypothesis is based on findings in human subjects showing that insulin can reach the brain via nasal cavities, … applied to nasal cavities for 15 days, and two major outcome measures will be assessed to evaluate the therapeutic …